Docket Room
HB 1426·MD·house

Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

Passed One ChamberFiled Feb 13, 2026
Sponsor: Solomon
Latest Action

In the Senate - First Reading Senate Rules

Apr 11, 2026

Summary

The bill lets the Maryland State Board of Pharmacy issue permits for pharmacies that only serve clinical research trials. It permits doctors, nurses or other licensed providers to hold an ownership stake in such pharmacies if a licensed pharmacist is on‑site and referral fees are prohibited. The change also removes experimental treatments from the legal definition of “practice of medicine,” so they don’t trigger usual licensing requirements.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 1426 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice